© 2000 American Heart Association, Inc.
Integrative Physiology |
Role of Kinins in the Control of Renal Papillary Blood Flow, Pressure Natriuresis, and Arterial Pressure
From the Departamento de Fisiología (J.T., M.I.M., M.G.S., F.J.F.), Facultad de Medicina, Murcia, Spain, and Hoechst AG (K.J.W.), Frankfurt, Germany.
Correspondence to Francisco J. Fenoy, Departamento de Fisiología y Farmacología, Facultad de Medicina, Campus de Espinardo, 30100-Murcia, Spain. E-mail fjfenoy{at}fcu.um.es
Abstract—The present study evaluated the effects of blocking kinins with the bradykinin B2 receptor antagonist Hoe140 on the relationship between renal perfusion pressure, papillary blood flow (PBF), and sodium excretion. To determine the relevance of renal kinins in the long-term control of arterial pressure, the effect of a chronic intrarenal infusion of Hoe140 on arterial pressure and sodium balance was also studied. PBF was not autoregulated in volume-expanded rats, and the administration of Hoe140 reduced PBF (-30%) and improved PBF autoregulation. The kinin antagonist also decreased sodium excretion (-35%) and blunted pressure natriuresis with no whole-kidney renal hemodynamic changes. These effects may be mediated through nitric oxide (NO), because in rats pretreated with NG-nitro-L-arginine methyl ester, Hoe140 had no additional effects on PBF or pressure natriuresis. A role for NO in mediating the renal response to Hoe140 is also supported by the finding that Hoe140 reduced basal urinary NO3-/NO2- excretion (-33%), and it blunted the arterial pressure–induced increase in NO3-/NO2- excretion, which is compatible with the idea that the pressure-natriuresis response may be mediated through kinins and NO. The importance of kinins in long-term regulation of arterial pressure is demonstrated by the severe arterial hypertension (172±6 mm Hg) induced during the chronic intrarenal infusion of Hoe140 associated with sodium and volume retention. These data suggest that renal kinins and NO may be a part of the renal mechanism coupling changes in arterial pressure with modifications in PBF and sodium excretion, therefore contributing to the long-term control of arterial pressure.
Key Words: bradykinin • nitric oxide • renal medulla • kidney • renal hemodynamics
This article has been cited by other articles:
 |
|
 |
|
  J. Xu, O. A. Carretero, Y. Sun, E. G. Shesely, N.-E. Rhaleb, Y.-H. Liu, T.-D. Liao, J. J. Yang, M. Bader, and X.-P. Yang Role of the B1 Kinin Receptor in the Regulation of Cardiac Function and Remodeling After Myocardial Infarction Hypertension, April 1, 2005; 45(4): 747 - 753. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X.-H. Jin, H. E. McGrath, J. J. Gildea, H. M. Siragy, R. A. Felder, and R. M. Carey Renal Interstitial Guanosine Cyclic 3', 5'-Monophosphate Mediates Pressure-Natriuresis Via Protein Kinase G Hypertension, May 1, 2004; 43(5): 1133 - 1139. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Matsuda, K. Hayashi, S. Wakino, E. Kubota, M. Honda, H. Tokuyama, I. Takamatsu, S. Tatematsu, and T. Saruta Role of Endothelium-Derived Hyperpolarizing Factor in ACE Inhibitor-Induced Renal Vasodilation in Vivo Hypertension, March 1, 2004; 43(3): 603 - 609. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. F. Milia, V. Gross, R. Plehm, J. A. De Silva Jr, M. Bader, and F. C. Luft Normal Blood Pressure and Renal Function in Mice Lacking the Bradykinin B2 Receptor Hypertension, June 1, 2001; 37(6): 1473 - 1479. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Maly, L. Karasova, M. Simova, S. Vitko, and S. S. El-Dahr Angiotensin II-Induced Hypertension in Bradykinin B2 Receptor Knockout Mice Hypertension, March 1, 2001; 37(3): 967 - 973. [Abstract] [Full Text] [PDF]
|
|